Institutional members access full text with Ovid®

First-line use of enfuvirtide-containing HAART regimen with dramatic clinical and immunological improvement in three cases

Bourgarit, Annea; Lascoux, Carolinea; Palmer, Pierreb; Tuleja, Ewaa; Pintado, Clairea; Farge, Dominiquea; Sereni, Daniela

doi: 10.1097/01.aids.0000199826.72359.9d
Correspondence